CBD is the most exciting and perhaps controversial new ingredient in decades. Despite a government crackdown on illegal sales, consumers are clamoring for CBD-infused products. On this week’s episode, we explore what is driving demand for CBD, and we lay out the best- and worst-case scenarios for the development of the CBD market. This episode features a full house for the first time since December: Global Strategist Stephen Rannekleiv, Senior Analyst Jim Watson, and Labradoodle Analyst Bourcard Nesin.